Silo Pharma Inc.

NASDAQ: SILO · Real-Time Price · USD
0.71
0.02 (2.59%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.63%
After-hours: Aug 15, 2025, 07:49 PM EDT

Silo Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
18.02K 18.03K 18.03K 18.02K 18.02K 18.03K 18.03K 18.02K 18.02K 18.03K 18.03K 18.02K 18.02K 18.03K 18.03K 18.02K 68.08K 47.43K
Cost of Revenue
1.46K 1.46K 1.46K 1.46K -171.89K 174.81K 162.35K 1.46K 1.46K 1.46K 1.46K 1.46K 1.46K 1.46K 1.46K 1.46K 38.5K 31.95K
Gross Profit
16.57K 16.57K 16.57K 16.57K 189.91K -156.78K -144.32K 16.57K 16.57K 16.57K 16.57K 16.57K 16.57K 16.57K 16.57K 16.57K 29.59K 15.48K
Operating Income
-1.25M -1.09M -1.81M -1.01M -1M -879.51K -1.16M -773.4K -1.11M -803.49K -1.66M -949.15K -494.29K -547.26K -942.42K -463.94K -510.03K -968.1K
Interest Income
n/a 61.83K 83.01K 84.94K 77.04K 88.18K 108.38K 116.18K 109.58K 64.39K 70.86K 981.00 377.00 415.00 1.21K n/a n/a n/a
Pretax Income
-1.2M -1.03M -1.73M -928.81K -931.78K -801.67K -1.05M -660.16K -1.01M -906.4K -1.66M -983.25K -658.4K -602.91K -1.06M 6.49M -461.99K -930.7K
Net Income
-1.2M -1.03M -1.73M -928.81K -931.78K -801.67K -1.12M -660.16K -1.01M -906.4K -1.66M -1.02M -822.14K -604.07K -1.09M 6.39M -461.99K -930.7K
Selling & General & Admin
52.97K 516.73K 754.2K 59.35K 626.52K 577.84K 843.33K 615.47K 1M 617.14K 1.04M 589.92K 405.18K 393.55K 548.03K 439.99K 473.13K 923.1K
Research & Development
717.25K 593.96K 1.08M 517.55K 392.82K 318.24K 336.96K 174.5K 130.72K 202.91K 634.68K 375.8K 105.68K 170.28K 475.95K 70.51K 112.5K 67.99K
Other Expenses
493.44K -181.56K n/a 448.26K n/a n/a n/a n/a n/a n/a n/a n/a -283 n/a n/a n/a n/a n/a
Operating Expenses
1.26M 929.13K 1.83M 1.03M 1.02M 896.08K 1.18M 789.96K 1.13M 820.05K 1.67M 965.72K 510.85K 563.83K 1.02M 510.51K 585.62K 991.09K
Interest Expense
-1.65K -2.07K 274.00 1.08K 1.86K 1.87K 273.00 1.08K 1.86K 1.66K 71.66K n/a n/a n/a 164.00 483.00 1.04K 1.35K
Selling & Marketing Expenses
n/a n/a n/a -199.54K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.27M 1.11M 1.83M 1.03M 1.02M 897.54K 1.18M 791.42K 1.13M 821.51K 1.67M 967.18K 512.31K 565.28K 1.03M 511.97K 624.12K 1.02M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.16K 33.11K 163.74K 1.16K 5.74K 19.13K n/a 8.85K
Shares Outstanding (Basic)
6.28M 4.48M 4.48M 4.3M 3.05M 2.87M 2.91M 3.11M 3.15M 3.16M 2.14M 2M 1.99M 1.97M 1.9M 1.97M 1.94M 1.7M
Shares Outstanding (Diluted)
6.28M 4.48M 4.48M 4.3M 3.05M 2.87M 2.91M 3.11M 3.15M 3.16M 2.14M 2M 1.99M 1.97M 1.92M 1.99M 1.94M 1.7M
EPS (Basic)
-0.19 -0.23 -0.39 -0.22 -0.31 -0.28 -0.39 -0.21 -0.32 -0.29 -0.78 -0.51 -0.41 -0.31 -0.57 3.16 -0.24 -0.55
EPS (Diluted)
-0.19 -0.23 -0.39 -0.22 -0.31 -0.28 -0.39 -0.21 -0.32 -0.29 -0.78 -0.51 -0.41 -0.31 -0.57 3.16 -0.24 -0.55
EBITDA
-1.25M -1.09M -1.79M -924.64K -929.92K -799.8K -1.05M -659.08K -1.01M -904.74K -1.84M -949.15K -494.29K -527.26K -1.06M -463.94K -510.03K -929.35K
EBIT
n/a -1.03M -1.73M -927.73K -929.92K -799.8K -1.05M -659.08K -1.01M -904.74K -1.91M -983.25K -658.4K -602.91K -1.06M -493.94K -482.85K -929.35K
Depreciation & Amortization
n/a 3.09K 3.09K 3.09K -43.28K 43.28K n/a n/a 109.58K -101.26K -182.71K 35.07K 164.21K 56.06K -140.36K -30K -46K -7.5K